Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: No message by the company
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Milestone,

I think most investors would consider a PTO final rejection as an invalidation of the 336. Technically it may not be, but realistically it carries no weight in the tech community at the moment, at least not in the USA.



Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply